Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions.
Celebrating 90 years of innovation #UCB90
UCB’s 90-year book is a goldmine to discover!
Twitter Feed
-
With @WeForest, UCB will ensure that about 12 000 hectares of degraded woodland in Ethiopia’s Tigray will be restored resulting in the sequestration of nearly 200 000 tons of CO2 by 2030 #UCB90 #Environment https://t.co/K50xSffHFY https://t.co/9pUR9Dhgt7
— UCB News (@ucb_news) 17.12.2018 -
Thank you! it was great to celebrate surrounded by so many esteemed guests. @DBoBruessel #UCB90 https://t.co/hFODtTvoty
— UCB News (@ucb_news) 14.12.2018 -
Guest were duly impressed by the wearable technology on display. Thank you for the great partnership @byteflies #UCB90 https://t.co/raZgPanki0
— UCB News (@ucb_news) 14.12.2018
Highlights
At UCB, we take our responsibility to the planet very seriously.
